Merck & Co. Inc. (NYSE:MRK) saw a downside of -1.60% to close Friday at $80.63 after subtracting -$1.31 on the day. The 5-day average trading volume is 25,289,039 shares of the company’s common stock. It has gained $84.56 in the past week. An average of 22,174,949 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 14,170,786.
MRK’s 1-month performance is 9.23% or $5.27 on its low of $70.89 reached on 09/17/21. The company’s shares have touched a 52-week low of $68.38 and high of $84.56, with the stock’s rally to the 52-week high happening on 01/11/21. YTD, MRK has achieved 3.37% or -$1.17. However, the current price is down -4.65%% from the 52-week high price.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
On May 10, 154 days have gone by since the last insider trading activity for Merck & Co. Inc. (MRK). Clyburn Frank (EVP & Pres ? Human Health) most recently sold 19,324 shares at $78.32 per share on May 10. This transaction cost the insider $1,513,440. Chairman, President & CEO, FRAZIER KENNETH C, sold 280,000 shares at a price of $81.42 on Nov 09.
The company’s PE ratio for the last five years has touched a high of 127.73 and a low of 16.64. MRK stock has a beta of 0.41. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 4.40 while the price-to-book (PB) in the most recent quarter is 6.14.
Merck & Co. Inc. pays an annual dividend of $2.60 per share. Its dividend yield is 3.22% and the payout ratio is 116.30%. MRK’s most recent quarterly dividend payment was made on Oct. 7, when it paid $0.65 a share compared with prior rate of $0.65, down 0.0% from last year’s. The company has boosted its dividend for the last 10 consecutive years with the latest dividend increase of $0.04 reported on Tuesday November 17 2020. Measured over the last 3 years, the Dividend has been growing by 31.22% yearly.
It is projected that Merck & Co. Inc.’s next ex-dividend date will be on 15-Dec. MRK is expected to distribute $0.65 as its next dividend.
Merck & Co. Inc.’s quick ratio for the period ended June 29 was 1.10, with the current ratio over the same period at 1.30 meaning that MRK stock is able to fulfill its debt obligations. As well, the company’s long term debt to equity for the quarter ending June 29 was 0.72, while the total debt to equity was 0.80. In terms of profitability, the gross margin trailing 12 months is 68.30%. The trailing 12-month EBITDA margin is 33.71% while for the period ending June 29; Merck & Co. Inc.’s operating margin was 10.60%. The firm’s gross profit as reported stood at $32.51 billion against revenue of $47.99 billion.
For the quarterly period ending June 29 this year, Net income and sales went down compared to those figures reported in the previous quarter. Analysts expected MRK to announce $1.31 per share in earnings in its latest quarter, but it posted $1.31, representing a 0.00% surprise. EBITDA for the quarter stood at more than $2.39 billion. MRK stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 57.3 billion, with total debt at $26.52 billion. Shareholders hold equity totaling $2.53 billion
Let’s look briefly at Merck & Co. Inc. (MRK) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 08 October was 64.66% to suggest the stock is trending Neutral, with historical volatility in this time period at 44.84%.
The stock’s 5-day moving average is $81.59, reflecting a -0.95% or -$0.77 change from its current price. MRK is currently trading +9.78% above its 20-day SMA, +1.57% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 and SMA200 by +4.81% and +1.52% respectively.
Stochastic %K and %D was 73.75% and 76.75% and the average true range (ATR) pointed at 2.11. The RSI (14) points at 63.47%, while the 14-day stochastic is at 69.27% with the period’s ATR at 1.89. The stock’s 9-day MACD Oscillator is pointing at 1.87 and 4.16 on the 14-day charts.
In the most recent analyst report for Merck & Co. Inc. (NYSE: MRK), Morgan Stanley downgraded it to an Equal-weight rating. They previously had an Overweight rating on the stock. Analysts offering their rating for MRK stock have a consensus rating for the stock as Overweight. Currently, 0 brokerage advisors rate MRK as a “sell,”, while 7 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 4 rates the stock as overweight while 10 have offered a “buy” rating.
What is MRK’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $82.00 and a high of $107.00, with their median price target at $93.50. Looking at these predictions, the average price target given by analysts is for Merck & Co. Inc. (MRK) stock is $94.89.